However, the levels of ZNF750 promoter methylation are comparable between the cell lines tested (Figure 4D), suggesting that alternative molecular mechanisms are responsible for the downregulation of ZNF750 expression in prostate cancer cell lines. The gene discussed is ZNF750; the disease is prostate carcinoma.